Evidence map›Paper›PMID 31293389›Full record

ArticleFrontiers in cellular neuroscience2019

Combined Cyclosporin A and Hypothermia Treatment Inhibits Activation of BV-2 Microglia but Induces an Inflammatory Response in an Ischemia/Reperfusion Hippocampal Slice Culture Model.

Sylvia J Wowro, Giang Tong, Jana Krech, Nele Rolfs, Felix Berger, Katharina R L Schmitt

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular neuroscience, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Sylvia J WowroDepartment of Congenital Heart Disease/Pediatric Cardiology, Universitäres Herzzentrum Berlin - Medical Heart Center of Charité and German Heart Institute Berlin, Berlin, Germany.
Giang TongDepartment of Congenital Heart Disease/Pediatric Cardiology, Universitäres Herzzentrum Berlin - Medical Heart Center of Charité and German Heart Institute Berlin, Berlin, Germany.
Jana KrechDepartment of Congenital Heart Disease/Pediatric Cardiology, Universitäres Herzzentrum Berlin - Medical Heart Center of Charité and German Heart Institute Berlin, Berlin, Germany.
Nele RolfsDepartment of Congenital Heart Disease/Pediatric Cardiology, Universitäres Herzzentrum Berlin - Medical Heart Center of Charité and German Heart Institute Berlin, Berlin, Germany.
Felix BergerDepartment of Congenital Heart Disease/Pediatric Cardiology, Universitäres Herzzentrum Berlin - Medical Heart Center of Charité and German Heart Institute Berlin, Berlin, Germany.
Katharina R L SchmittDepartment of Congenital Heart Disease/Pediatric Cardiology, Universitäres Herzzentrum Berlin - Medical Heart Center of Charité and German Heart Institute Berlin, Berlin, Germany.
Charité - Universitätsmedizin Berlin · DEFreie Universität Berlin · DEHumboldt-Universität zu Berlin · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionHypothermia attenuates cerebral ischemia-induced neuronal cell death associated with neuroinflammation. The calcineurin inhibitor cyclosporin A (CsA) has been shown to be neuroprotective by minimizing activation of inflammatory pathways. Therefore, we investigated whether the combination of hypothermia and treatment with CsA has neuroprotective effects in an oxygen-glucose deprivation/reperfusion (OGD/R) injury model in neuronal and BV-2 microglia monocultures, as well as in an organotypic hippocampal slice culture (OHSC).

methodsMurine primary neurons, BV-2 microglia, and OHSC were pretreated with CsA and exposed to 1 h OGD (0.2% O

resultsExposure to OGD plus 10 μM CsA was sufficient to induce necrotic cell death and subsequent release of DAMPs in neurons but not BV-2 microglia. Moreover, OGD/R-induced secondary injury was also observed only in the neurons, which was not attenuated by cooling and no increased toxicity by CsA was observed. BV-2 microglia were not sensitive to OGD/R-induced injury but were susceptible to CsA-induced toxicity in a dose dependent manner, which was minimized by hypothermia. CsA attenuated IL-1β and Iba1 expressions in BV-2 microglia exposed to OGD/R. Hypothermia reduced IL-1β and iNOS expressions but induced TNF-α and Iba1 expressions in the microglia. However, these observations did not translate to the

conclusionTreatment with CsA has neurotoxic effects on primary neurons exposed to OGD but could inhibit BV-2 microglia activation. However, CsA and hypothermia treatment after ischemia/reperfusion injury results in cytotoxic neuroinflammation in the complex

Indexed as

BV-2 microgliacyclosporin ADAMPshypothermiainflammationorganotypic hippocampal slice cultureoxygen-glucose deprivation/reperfusionprimary neuron

Identifiers

PMID31293389
PMCPMC6603137
OpenAlexW2948627236

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.